Predicting response to treatment in human cancers of the uterine cervix: Sequential biopsies during external beam radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 58, Issue 2, 2004, Pages 555-560

  Durand, Ralph E ^a,b   Aquino Parsons, Christina ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

Accelerated repopulation; Cervix; Kinetics; Predictive assays; Radiotherapy

Indexed keywords

BIOPSY; CYTOLOGY; DNA; PATIENT MONITORING; RADIOTHERAPY; TUMORS;

CHEMORADIOTHERAPY;

ONCOLOGY;

ADULT; AGED; CANCER CELL; CANCER DIAGNOSIS; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL SUBPOPULATION; CELL SUSPENSION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DNA CONTENT; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; METASTASIS; PREDICTION; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER;

EID: 0942268134     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2003.09.066     Document Type: Conference Paper

References (16)

1. Withers H.R., Taylor J.M., Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 27:1988;131-146.
2. Begg A.C., Hofland I., van Glabbeke M., et al. Predictive value of potential doubling time for radiotherapy of head and neck tumor patients Results from the EORTC cooperative trial 22851 . Semin Radiat Oncol. 2:1992;22-25.
3. Dische S., Saunders M., Barrett A., et al. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol. 44:1997;123-136.
4. Fowler J.F. Biological factors influencing optimum fractionation in radiation therapy. Acta Oncol. 40:2003;712-717.
5. Nguyen L.N., Ang K.K. Radiotherapy for cancer of the head and neck Altered fractionation regimens . Lancet Oncol. 3:2002;693-701.
6. Begg A.C., Haustermans K., Hart A.A., et al. The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer A multicenter analysis . Radiother Oncol. 50:1999;13-23.
7. Tsang R.W., Fyles A.W., Li Y., et al. Tumor proliferation and apoptosis in human uterine cervix carcinoma I Correlations between variables . Radiother Oncol. 50:1999;85-92.
8. Corvo R., Antognoni P., Sanguineti G. Biological predictors of response to radiotherapy in head and neck cancer Recent advances and emerging perspectives . Tumori. 87:2001;355-363.
9. Lehman M., Thomas G. Is concurrent chemotherapy and radiotherapy the new standard of care for locally advanced cervical cancer? Int J Gynecol Cancer. 11:2001;87-99.
10. Pearcey R., Brundage M., Drouin P., et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol. 20:2002;966-972.
11. Brown J.M., Giaccia A.J. Tumour hypoxia The picture has changed in the 1990s . Int J Radiat Biol. 65:1994;95-102.
12. Durand R.E., Aquino-Parsons C. Non-constant tumour blood flow Implications for therapy . Acta Oncol. 40:2001;862-869.
13. Dewhirst M.W., LaRue S.M., Gerweck L.E. Tumor physiology and cell kinetics. Semin Vet Med Surg. 10:1995;148-157.
14. Durand R.E. Intermittent blood flow in solid tumours - an under-appreciated source of "drug resistance" Cancer Metastasis Rev. 20:2001;57-61.
15. Durand R.E., Aquino-Parsons C. The clinical relevance of intermittent tumour blood flow. Acta Oncol. 40:2001;929-936.
16. Chu K., Leonhardt E.A., Trinh M., et al. Computerized video time-lapse (CVTL) analysis of cell death kinetics in human bladder carcinoma cells (EJ30) X-irradiated in different phases of the cell cycle. Radiat Res. 158:2002;667-677.